Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Drug Resistance
66%
Infectious Disease
56%
Prevalence
54%
Human Immunodeficiency Virus
51%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Human Leukocyte Antigen
33%
Hepatitis B Virus
33%
COVID-19
26%
Dynamics
26%
Immunology
25%
Antimicrobial Resistance
23%
Genetic Variability
22%
Infectious Agent
21%
Seroprevalence
21%
Viral Disease
16%
Gram-Negative Bacteria
16%
Lower Respiratory Tract
16%
Molecular Epidemiology
16%
Genetic Recombination
16%
Allele
16%
Hepatitis C Virus Genotype 1
16%
Antibiotic-Resistant Bacteria
16%
Lineages
16%
Human Respiratory Syncytial Virus
16%
Staphylococcus Aureus
16%
Pneumococcus
16%
Poliomyelitis Virus
16%
Human Poliovirus 2
16%
Cladistics
13%
Evolution
11%
T Cell
10%
Phylogeny
10%
Salmonella
9%
Seropositivity
8%
Immunoglobulin M
8%
Treponema pallidum
8%
Hepatitis C
8%
Blood Plasma
7%
ABO Blood Group System
7%
Blood Group
7%
Polymerase Chain Reaction
6%
Virus Strain
6%
Immune Escape
6%
Antiviral Resistance
6%
Web of Science
6%
Medline
6%
Multidrug Resistance
6%
Population Research
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
53%
Drug Resistance
50%
Infection
47%
Case-Control Study
22%
Prevalence
20%
Gram Negative Bacterium
16%
Antimicrobial Resistance
16%
Bloodstream Infection
16%
Lactobacillus
16%
Human Immunodeficiency Virus 1
16%
Hepatitis B
16%
Epidemic
16%
Antibiotic Resistance
16%
Virus Infection
16%
Poliomyelitis Virus
16%
Human Poliovirus 2
16%
Seroepidemiology
16%
SARS Coronavirus
16%
Hepatitis B Virus
13%
Infectious Agent
11%
Flaccid Paralysis
10%
Salmonella
9%
Nonnucleoside Reverse Transcriptase Inhibitor
7%
Poliomyelitis
6%
Pandemic
6%
Antibiotics
6%
Vagina Flora
5%
Wound Healing
5%
Vaginitis
5%
Tropical Disease
5%
Medicine and Dentistry
Drug Resistance
33%
Human Immunodeficiency Virus
33%
Infection
33%
Systematic Review
33%
Prevalence
22%
Diagnosis
20%
Lactobacillus
16%
Hepatitis B
16%
Antiretroviral Therapy
16%
Molecular Epidemiology
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
COVID-19 Diagnostics
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Poliomyelitis Virus
16%
Human Poliovirus 2
16%
Seroepidemiology
16%
Hepatitis B Virus
13%
Flaccid Paralysis
10%
Public Health
8%
Pathogen
8%
Polymerase Chain Reaction
6%
COVID-19
6%
Low and Middle Income Countries
6%
Health Care Cost
6%
Rapid Diagnostic Test
6%
Molecular Diagnostics
6%
Poliomyelitis
6%
Gynecology
5%
Wound Healing
5%
Case-Control Study
5%
Vaginitis
5%
Medical Care
5%
Concoction
5%
Obstetrics
5%
Nonnucleoside Reverse Transcriptase Inhibitor
5%
Tropical Disease
5%
